168 related articles for article (PubMed ID: 23752601)
1. [Selenium in Graves' disease].
Kryczyk J; Zagrodzki P
Postepy Hig Med Dosw (Online); 2013 May; 67():491-8. PubMed ID: 23752601
[TBL] [Abstract][Full Text] [Related]
2. Selenium in the Treatment of Graves' Hyperthyroidism and Eye Disease.
Lanzolla G; Marinò M; Marcocci C
Front Endocrinol (Lausanne); 2020; 11():608428. PubMed ID: 33574798
[TBL] [Abstract][Full Text] [Related]
3. Significance of selenium in thyroid physiology and pathology.
Lacka K; Szeliga A
Pol Merkur Lekarski; 2015 Jun; 38(228):348-53. PubMed ID: 26098657
[TBL] [Abstract][Full Text] [Related]
4. The role of selenium in thyroid autoimmunity and cancer.
Duntas LH
Thyroid; 2006 May; 16(5):455-60. PubMed ID: 16756467
[TBL] [Abstract][Full Text] [Related]
5. Selenium involvement in mitochondrial function in thyroid disorders.
Gheorghiu ML; Badiu C
Hormones (Athens); 2020 Mar; 19(1):25-30. PubMed ID: 31960358
[TBL] [Abstract][Full Text] [Related]
6. Dihydrotestosterone regulates oxidative stress and immunosuppressive cytokines in a female BALB/c mouse model of Graves' disease.
Zhao F; Wu L; Wang Y; Liu L; Yang F; Sun Y; Jiao X; Bao L; Chen P; Liang Q; Shi B
Autoimmunity; 2019 May; 52(3):117-125. PubMed ID: 31134819
[No Abstract] [Full Text] [Related]
7. Mechanistic Pathways of Selenium in the Treatment of Graves' Disease and Graves' Orbitopathy.
Marinò M; Dottore GR; Leo M; Marcocci C
Horm Metab Res; 2018 Dec; 50(12):887-893. PubMed ID: 30096720
[TBL] [Abstract][Full Text] [Related]
8. Concentration of selenium in the whole blood and the thyroid tissue of patients with various thyroid diseases.
Kucharzewski M; Braziewicz J; Majewska U; Góźdź S
Biol Trace Elem Res; 2002 Jul; 88(1):25-30. PubMed ID: 12117262
[TBL] [Abstract][Full Text] [Related]
9. Fas/FasL mediated apoptosis of thyrocytes in Graves' disease.
Sera N; Kawakami A; Nakashima T; Nakamura H; Imaizumi M; Koji T; Abe Y; Usa T; Tominaga T; Ejima E; Ashizawa K; Yokoyama N; Ishikawa N; Ito K; Eguchi K
Clin Exp Immunol; 2001 May; 124(2):197-207. PubMed ID: 11422195
[TBL] [Abstract][Full Text] [Related]
10. Selenium supplementation and autoimmune thyroid diseases.
Sturniolo G; Mesa J
Endocrinol Nutr; 2013 Oct; 60(8):423-6. PubMed ID: 24021243
[No Abstract] [Full Text] [Related]
11. Peripheral parameters of oxidative stress in patients with infiltrative Graves' ophthalmopathy treated with corticosteroids.
Bednarek J; Wysocki H; Sowiński J
Immunol Lett; 2004 May; 93(2-3):227-32. PubMed ID: 15158621
[TBL] [Abstract][Full Text] [Related]
12. Selenium and the thyroid gland: more good news for clinicians.
Drutel A; Archambeaud F; Caron P
Clin Endocrinol (Oxf); 2013 Feb; 78(2):155-64. PubMed ID: 23046013
[TBL] [Abstract][Full Text] [Related]
13. Effects of selenium on short-term control of hyperthyroidism due to Graves' disease treated with methimazole: results of a randomized clinical trial.
Leo M; Bartalena L; Rotondo Dottore G; Piantanida E; Premoli P; Ionni I; Di Cera M; Masiello E; Sassi L; Tanda ML; Latrofa F; Vitti P; Marcocci C; Marinò M
J Endocrinol Invest; 2017 Mar; 40(3):281-287. PubMed ID: 27734319
[TBL] [Abstract][Full Text] [Related]
14. Expression of intercellular adhesion molecule-1 in thyroid follicular cells in autoimmune, non-autoimmune and neoplastic diseases of the thyroid gland: discordance with HLA.
Tolosa E; Roura C; Catálfamo M; Martí M; Lucas-Martín A; Sanmartí A; Salinas I; Obiols G; Foz-Sala M; Pujol-Borrell R
J Autoimmun; 1992 Feb; 5(1):107-18. PubMed ID: 1348415
[TBL] [Abstract][Full Text] [Related]
15. Enhancement of endogenous defenses against ROS by supra-nutritional level of selenium is more safe and effective than antioxidant supplementation in reducing hypertensive target organ damage.
Zhou X; Ji WJ; Zhu Y; He B; Li H; Huang TG; Li YM
Med Hypotheses; 2007; 68(5):952-6. PubMed ID: 17126495
[TBL] [Abstract][Full Text] [Related]
16. [The role of selenium in endocrine system diseases].
Balázs C; Rácz K
Orv Hetil; 2013 Oct; 154(41):1628-35. PubMed ID: 24095912
[TBL] [Abstract][Full Text] [Related]
17. The trace element selenium and the thyroid gland.
Köhrle J
Biochimie; 1999 May; 81(5):527-33. PubMed ID: 10403185
[TBL] [Abstract][Full Text] [Related]
18. [Free radical concepts in the etiopathogenesis of Graves-Basedow disease].
Komosińska-Vassev K; Olczyk K; Winsz K
Postepy Hig Med Dosw; 2000; 54(2):225-37. PubMed ID: 10857382
[TBL] [Abstract][Full Text] [Related]
19. Free radical activity and antioxidant defense mechanisms in patients with hyperthyroidism due to Graves' disease during therapy.
Komosinska-Vassev K; Olczyk K; Kucharz EJ; Marcisz C; Winsz-Szczotka K; Kotulska A
Clin Chim Acta; 2000 Oct; 300(1-2):107-17. PubMed ID: 10958867
[TBL] [Abstract][Full Text] [Related]
20. Selenium and the thyroid: how the relationship was established.
Corvilain B; Contempré B; Longombé AO; Goyens P; Gervy-Decoster C; Lamy F; Vanderpas JB; Dumont JE
Am J Clin Nutr; 1993 Feb; 57(2 Suppl):244S-248S. PubMed ID: 8427197
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
